NCT00396019View on ClinicalTrials.gov

Study of PEG-Intron for Plexiform Neurofibromas

PHASE2CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Plexiform Neurofibroma
Interventions
DRUG

PEG-Intron

Trial Locations (1)

15224

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Pittsburgh

OTHER

NCT00396019 - Study of PEG-Intron for Plexiform Neurofibromas | Biotech Hunter | Biotech Hunter